Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prodromal Markers of α-synucleinopathy Neurodegeneration in the First-degree Relatives of Patients With Psychiatric Disorders Comorbid With REM Sleep Behavior Disorder

NCT03595475 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT03595475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03595475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prodromal Markers of α-synucleinopathy Neurodegeneration in the First-degree Relatives of Patients With Psychiatric Disorders Comorbid With REM Sleep Behavior Disorder
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
October 1, 2017
Completion date
March 31, 2022
Enrollment
408 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rem sleep behavior disorder